Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2020

View Archived Issues

ADAM9 expression correlates with poor survival in TNBC

Discovery of novel BET protein degraders as oncolytic drug candidates

Crosstalk between sex, stress hormones affects immunity

Astrocytes, endocannabinoids, metabolism cooperate to affect behavior

Liver-specific silencing of MCJ reduces steatosis, inflammation and fibrosis in NASH mouse models

Roche synthesizes new imidazopyrazine antibacterials

Humanwell Healthcare, Hubei Bio-Pharmaceutical patent PDE4 inhibitors

Phase II study of CS-02 meets primary endpoint

New SMARCA2 inhibitors identified at Bayer

Imperial Innovations Group presents N-myristoyltransferase inhibitors

Svenox Pharmaceuticals presents new antitubercular compounds

Aptahem and University Health Network collaborate to develop Apta-1 for treatment of COVID-19

First-in-human study of INV-1120

Aligos Therapeutics presents preclinical data on ALG-031048

NBE-Therapeutics initiates phase I/II study of NBE-002

Enrollment ongoing in phase I study of KBL-693

Celldex Therapeutics starts enrollment in phase I study of CDX-527

BRAF inhibitor ABM-1310 displays potent efficacy in xenograft cancer models

Oragenics advances TerraCoV2, ends development of AG-013 for oral mucositis

Alzumab approved in India for emergency use to treat CRS in patients with COVID-19-related ARDS

Australia's TGA grants provisional approval to remdesivir

Beta Pharma begins phase I/II study of BPI-1178 in advanced solid tumors and breast cancer

Mutation drives checkpoint resistance in gastric cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...